Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Kang

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Nature Reviews. Nephrology|December 28, 2020
SGLT2 inhibitors may offer benefit beyond diabetesAmy Kang, Meg J Jardine
The Medical Journal of Australia|December 15, 2015
MondayitisYun Tae Hwang, Amy Kang
Therapeutic Advances in Infectious Disease|February 7, 2022
Evaluation of step-down oral antibiotic therapy for uncomplicated streptococcal bloodstream infections on clinical outcomesAmy Kang, Richard Beuttler, Emi Minejima
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 25, 2018
Effects of clinical decision support and pharmacist prescribing authority on a therapeutic interchange programAmy Kang, Ashley Thompson, Johnny Rau, et al.
Vaccine|January 28, 2019
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysisNirma Khatri Vadlamudi, Kamalpreet Parhar, Kim Lorenzo Altre Malana, et al.
Internal Medicine Journal|June 26, 2026
A scoping review of specialist hypertension clinicsDestiny O'Dea, Andrew Siyoung Chung, Arunima Jain, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 22, 2020
Cost-benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycinBrian V Lee, Gary Fong, Michael Bolaris, et al.
The Journal of Rheumatology|November 3, 2018
High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated VasculitisAmy Kang, Marilina Antonelou, Nikki L Wong, et al.
The Journal of Rheumatology|July 3, 2019
Dr. Kang, <i>et al,</i> replyAmy Kang, Marilina Antonelou, Nikki L Wong, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2021
'Cost-benefit analysis comparing trough, two-level AUC, and Bayesian AUC dosing for vancomycin': authors' replyBrian V Lee, Gary Fong, Michael Bolaris, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Nature Reviews. Nephrology|December 28, 2020
SGLT2 inhibitors may offer benefit beyond diabetesAmy Kang, Meg J Jardine
The Medical Journal of Australia|December 15, 2015
MondayitisYun Tae Hwang, Amy Kang
Therapeutic Advances in Infectious Disease|February 7, 2022
Evaluation of step-down oral antibiotic therapy for uncomplicated streptococcal bloodstream infections on clinical outcomesAmy Kang, Richard Beuttler, Emi Minejima
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 25, 2018
Effects of clinical decision support and pharmacist prescribing authority on a therapeutic interchange programAmy Kang, Ashley Thompson, Johnny Rau, et al.
Vaccine|January 28, 2019
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysisNirma Khatri Vadlamudi, Kamalpreet Parhar, Kim Lorenzo Altre Malana, et al.
Internal Medicine Journal|June 26, 2026
A scoping review of specialist hypertension clinicsDestiny O'Dea, Andrew Siyoung Chung, Arunima Jain, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 22, 2020
Cost-benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycinBrian V Lee, Gary Fong, Michael Bolaris, et al.
The Journal of Rheumatology|November 3, 2018
High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated VasculitisAmy Kang, Marilina Antonelou, Nikki L Wong, et al.
The Journal of Rheumatology|July 3, 2019
Dr. Kang, <i>et al,</i> replyAmy Kang, Marilina Antonelou, Nikki L Wong, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2021
'Cost-benefit analysis comparing trough, two-level AUC, and Bayesian AUC dosing for vancomycin': authors' replyBrian V Lee, Gary Fong, Michael Bolaris, et al.
Pageof 4